Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Wombolt

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Cardiovascular Pharmacology|January 1, 1988
A randomized placebo-controlled comparison of amlodipine and atenolol in mild to moderate systemic hypertensionW H Frishman, R Brobyn, R D Brown, et al.
American Journal of Hypertension|October 1, 1992
A randomized, placebo-controlled, double-blind comparison of amlodipine and atenolol in patients with essential hypertensionB F Johnson, W H Frishman, R Brobyn, et al.
American Journal of Hypertension|April 1, 1988
Effect of doxazosin monotherapy on blood pressure and plasma lipids in patients with essential hypertensionL X Cubeddu, J L Pool, R Bloomfield, et al.
Clinical Transplantation|August 18, 2000
Mycophenolate mofetil, with cyclosporine and prednisone, reduces early rejection while allowing the use of less antilymphocytic agent induction and cyclosporine in renal recipients with delayed graft functionA N Arnold, D G Wombolt, T V Whelan, et al.
Clinical Nephrology|February 13, 1999
A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patientsG M Chertow, M Dillon, S K Burke, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1991
Once-daily fosinopril in the treatment of hypertensionR J Anderson, K L Duchin, R D Gore, et al.
Kidney International|May 1, 1979
Restrospective correlation of clinical and histologic findings of 189 exchanged kidneysN Ende, J C Pierce, F Westervelt, et al.
Transplantation|March 27, 1996
The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study GroupG Barone, C T Chang, M G Choc, et al.
Transplantation|March 27, 1996
The safety and tolerability of cyclosporine emulsion versus cyclosporine in a randomized, double-blind comparison in primary renal allograft recipients. The Neoral Study GroupG Barone, C M Bunke, M G Choc, et al.
Transplantation|March 15, 1997
Safety and tolerability of cyclosporine microemulsion versus cyclosporine: two-year data in primary renal allograft recipients: a report of the Neoral Study GroupM D Pescovitz, G Barone, M G Choc, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Cardiovascular Pharmacology|January 1, 1988
A randomized placebo-controlled comparison of amlodipine and atenolol in mild to moderate systemic hypertensionW H Frishman, R Brobyn, R D Brown, et al.
American Journal of Hypertension|October 1, 1992
A randomized, placebo-controlled, double-blind comparison of amlodipine and atenolol in patients with essential hypertensionB F Johnson, W H Frishman, R Brobyn, et al.
American Journal of Hypertension|April 1, 1988
Effect of doxazosin monotherapy on blood pressure and plasma lipids in patients with essential hypertensionL X Cubeddu, J L Pool, R Bloomfield, et al.
Clinical Transplantation|August 18, 2000
Mycophenolate mofetil, with cyclosporine and prednisone, reduces early rejection while allowing the use of less antilymphocytic agent induction and cyclosporine in renal recipients with delayed graft functionA N Arnold, D G Wombolt, T V Whelan, et al.
Clinical Nephrology|February 13, 1999
A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patientsG M Chertow, M Dillon, S K Burke, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1991
Once-daily fosinopril in the treatment of hypertensionR J Anderson, K L Duchin, R D Gore, et al.
Kidney International|May 1, 1979
Restrospective correlation of clinical and histologic findings of 189 exchanged kidneysN Ende, J C Pierce, F Westervelt, et al.
Transplantation|March 27, 1996
The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study GroupG Barone, C T Chang, M G Choc, et al.
Transplantation|March 27, 1996
The safety and tolerability of cyclosporine emulsion versus cyclosporine in a randomized, double-blind comparison in primary renal allograft recipients. The Neoral Study GroupG Barone, C M Bunke, M G Choc, et al.
Transplantation|March 15, 1997
Safety and tolerability of cyclosporine microemulsion versus cyclosporine: two-year data in primary renal allograft recipients: a report of the Neoral Study GroupM D Pescovitz, G Barone, M G Choc, et al.
Pageof 4